Zobrazeno 1 - 10
of 452
pro vyhledávání: '"Spanggaard I"'
Autor:
Saleh, M., Barve, M., Subbiah, V., Papadopoulos, K.P., Morgensztern, D., Mettu, N.B., Roychowdhury, S., Spanggaard, I., Veronese, M.L., Tian, C., Silverman, I.M., Gutierrez, M.
Publikováno v:
In ESMO Open July 2024 9(7)
Autor:
Jhaveri, K., Eli, L.D., Wildiers, H., Hurvitz, S.A., Guerrero-Zotano, A., Unni, N., Brufsky, A., Park, H., Waisman, J., Yang, E.S., Spanggaard, I., Reid, S., Burkard, M.E., Vinayak, S., Prat, A., Arnedos, M., Bidard, F.-C., Loi, S., Crown, J., Bhave, M., Piha-Paul, S.A., Suga, J.M., Chia, S., Saura, C., Garcia-Saenz, J.Á., Gambardella, V., de Miguel, M.J., Gal-Yam, E.N., Raphael, A., Stemmer, S.M., Ma, C., Hanker, A.B., Ye, D., Goldman, J.W., Bose, R., Peterson, L., Bell, J.S.K., Frazier, A., DiPrimeo, D., Wong, A., Arteaga, C.L., Solit, D.B.
Publikováno v:
In Annals of Oncology October 2023 34(10):885-898
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rodón J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrodon@mdanderson.org., Damian S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Furqan M; University of Iowa, Iowa City, IA, USA., García-Donas J; Centro Integral Oncologico Clara Campal, Madrid, Spain., Imai H; Tohoku University Hospital, Sendai-Shi, Japan., Italiano A; Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Spanggaard I; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Ueno M; Kanagawa Cancer Center, Yokohama, Japan., Yokota T; Shizuoka Cancer Center, Shizuoka, Japan., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Oliveira N; Incyte International Biosciences Sàrl, Morges, Switzerland., Li X; Incyte Corporation, Wilmington, DE, USA., Gilmartin A; Incyte Corporation, Wilmington, DE, USA., Schaffer M; Incyte Corporation, Wilmington, DE, USA., Goyal L; Mass General Cancer Center, Harvard Medical School, Boston, MA, USA. lgoyal@stanford.edu.; Stanford Cancer Center, Stanford School of Medicine, Stanford, CA, USA. lgoyal@stanford.edu.
Publikováno v:
Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2377.
Autor:
Rodón J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrodon@mdanderson.org., Damian S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Furqan M; University of Iowa, Iowa City, IA, USA., García-Donas J; Centro Integral Oncologico Clara Campal, Madrid, Spain., Imai H; Tohoku University Hospital, Sendai-Shi, Japan., Italiano A; Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Spanggaard I; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Ueno M; Kanagawa Cancer Center, Yokohama, Japan., Yokota T; Shizuoka Cancer Center, Shizuoka, Japan., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Oliveira N; Incyte International Biosciences Sàrl, Morges, Switzerland., Li X; Incyte Corporation, Wilmington, DE, USA., Gilmartin A; Incyte Corporation, Wilmington, DE, USA., Schaffer M; Incyte Corporation, Wilmington, DE, USA., Goyal L; Mass General Cancer Center, Harvard Medical School, Boston, MA, USA. lgoyal@stanford.edu.; Stanford Cancer Center, Stanford School of Medicine, Stanford, CA, USA. lgoyal@stanford.edu.
Publikováno v:
Nature medicine [Nat Med] 2024 Jun; Vol. 30 (6), pp. 1645-1654. Date of Electronic Publication: 2024 May 06.
Autor:
Li BT; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA. Electronic address: lib1@mskcc.org., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Naito Y; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Chiba, Japan., Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy., Aftimos P; Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium., Anderson I; Providence Medical Group, Santa Rosa, CA, USA., Curigliano G; Istituto Europeo di Oncologia, IRCCS Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy., de Miguel M; START Madrid Centro Integral Oncológico Clara Campal (CIOCC)-HM Sanchinarro University Hospital, Madrid, Spain., Kalra M; Ball Memorial Hospital (IU Health), Muncie, IN, USA., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea., Park JO; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Postel-Vinay S; Inserm Unit U981 Gustave Roussy, Villejuif, France; Cancer Institute, University College London, London, UK., Rha SY; Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea., Satoh T; Osaka University, Osaka, Japan., Spanggaard I; Department of Oncology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark., Michelini F; Translational Medicine, Oncology Research and Development, AstraZeneca, Waltham, MA, USA., Smith A; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, UK., Machado KK; Late Development Oncology, Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Saura C; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Jun; Vol. 25 (6), pp. 707-719. Date of Electronic Publication: 2024 May 03.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Agner BR; Afdeling for Kræftbehandling, Københavns Universitetshospital - Rigshospitalet., Riley CH; Afdeling for Blodsygdomme, Københavns Universitetshospital - Rigshospitalet., Petersen SL; Afdeling for Blodsygdomme, Københavns Universitetshospital - Rigshospitalet., Spanggaard I; Afdeling for Kræftbehandling, Københavns Universitetshospital - Rigshospitalet., Hutchings M; Afdeling for Blodsygdomme, Københavns Universitetshospital - Rigshospitalet., Rohrberg KS; Afdeling for Kræftbehandling, Københavns Universitetshospital - Rigshospitalet., Højgaard M; Afdeling for Kræftbehandling, Københavns Universitetshospital - Rigshospitalet.
Publikováno v:
Ugeskrift for laeger [Ugeskr Laeger] 2024 Feb 26; Vol. 186 (9). Date of Electronic Publication: 2024 Feb 26.
Autor:
Friedman CF; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: friedmac@mskcc.org., D'Souza A; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Bello Roufai D; Department of Medical Oncology, Institut Curie, Saint Cloud, France., Tinker AV; BC Cancer-Vancouver, Vancouver, British Columbia, Canada., de Miguel M; Ramón y Cajal University Hospital, Madrid, Spain., Gambardella V; Hospital Clínico Universitario de Valencia, Valencia, Spain., Goldman J; The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Loi S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Melisko ME; UCSF Early Phase Investigational Therapeutics, University of California San Francisco, San Francisco, CA, USA., Oaknin A; Gynecological Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain., Spanggaard I; University Hospital, Rigshospitalet, Copenhagen, Denmark., Shapiro GI; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., ElNaggar AC; West Cancer Center and Research Institute, Memphis, TN, USA., Panni S; Cremona Hospital, Cremona, Italy., Ravichandran V; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Frazier AL; Puma Biotechnology Inc, Los Angeles, CA, USA., DiPrimeo D; Puma Biotechnology Inc, Los Angeles, CA, USA., Eli LD; Puma Biotechnology Inc, Los Angeles, CA, USA., Solit DB; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Feb; Vol. 181, pp. 162-169. Date of Electronic Publication: 2024 Jan 11.
Autor:
Melero, I., Reis, B., Bardaji, M.J. Lostes, Spanggaard, I., Lee, D.H., Spicer, J., Thistlethwaite, F., Symeonides, S.N., Oh, D-Y., Hollebecque, A., Rieder, N., Schwalie, P., Badillo, S., Kumpesa, N., Thommen, A., Rusterholz, C., Cirovic, O., Kazantzidis, G., Garcia, V. Moreno, Epp, A.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S279-S280